The golden age of DDP-4 continuing high-speed growth along with its complexes

In the diabetes treatment market, DPP-4 is making high-speed growth. It is also observed that the switching is currently on procedure after launches of generics.

According to the Medipana News’s analysis result of outpatient prescriptions of DPP-4 type major products on the first quarter of the year based on the UBIST data, the 13 products recorded approximately KRW 78.342 billion prescription...